Simsek_2024_Oncol.Lett_27_34

Reference

Title : Downregulated GPD1 and MAGL protein levels as potential biomarkers for the metastasis of triple-negative breast tumors to axillary lymph nodes - Simsek_2024_Oncol.Lett_27_34
Author(s) : Simsek T , Bal Albayrak MG , Akpinar G , Canturk NZ , Kasap M
Ref : Oncol Lett , 27 :34 , 2024
Abstract :

Glycerol-3-phosphate dehydrogenase (GPD1) and monoacylglycerol lipase (MAGL) levels are known to be significantly downregulated in both the tissue and serum samples of patients with triple-negative breast cancer (TNBC), compared with other BC subtypes and healthy controls. As such, the association between GPD1 and MAGL levels and lymph node metastasis was evaluated in the present study. Utilizing western blotting, lymph node protein extracts from metastasized BC subtypes were analyzed and a significant downregulation of GPD1 and MAGL protein expression levels in the lymph node metastases was demonstrated in the TNBC subtype, compared with healthy controls. This finding further highlighted the potential use of these two proteins in early BC onset and metastasis detection.

PubMedSearch : Simsek_2024_Oncol.Lett_27_34
PubMedID: 38108074

Related information

Citations formats

Simsek T, Bal Albayrak MG, Akpinar G, Canturk NZ, Kasap M (2024)
Downregulated GPD1 and MAGL protein levels as potential biomarkers for the metastasis of triple-negative breast tumors to axillary lymph nodes
Oncol Lett 27 :34

Simsek T, Bal Albayrak MG, Akpinar G, Canturk NZ, Kasap M (2024)
Oncol Lett 27 :34